The US Supreme Court upheld a Tennessee law banning puberty blockers and cross-sex hormones for minors, aligning with a growing trend toward cautious treatment in some European countries. The ruling in US v Skrmetti, passed by a 6-3 majority, dismissed claims that the law discriminated based on sex, emphasizing that treatments were distinguished by medical condition, not biological sex. The court highlighted risks associated with gender medicalisation, citing evidence of regret among detransi...
